BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 9740825)

  • 1. [Treatment of discoid lupus erythematosus with sulfasalazine: 11 cases].
    Delaporte E; Catteau B; Sabbagh N; Gosselin P; Breuillard F; Doutre MS; Broly F; Piette F; Bergoend H
    Ann Dermatol Venereol; 1997; 124(2):151-6. PubMed ID: 9740825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus.
    Tlacuilo-Parra A; Guevara-Gutiérrez E; Gutiérrez-Murillo F; Soto-Ortiz A; Barba-Gómez F; Hernández-Torres M; Salazar-Páramo M
    Rheumatology (Oxford); 2005 Dec; 44(12):1564-8. PubMed ID: 16159951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thalidomide and thrombosis].
    Flageul B; Wallach D; Cavelier-Balloy B; Bachelez H; Carsuzaa F; Dubertret L
    Ann Dermatol Venereol; 2000 Feb; 127(2):171-4. PubMed ID: 10739975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thalidomide therapy for discoid lupus erythematosus].
    Lyakhovisky A; Baum S; Shpiro D; Salomon M; Trau H
    Harefuah; 2006 Jul; 145(7):489-92, 551. PubMed ID: 16900736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAT2 genotyping and efficacy of sulfasalazine in patients with chronic discoid lupus erythematosus.
    Sabbagh N; Delaporte E; Marez D; Lo-Guidice JM; Piette F; Broly F
    Pharmacogenetics; 1997 Apr; 7(2):131-5. PubMed ID: 9170150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy.
    Ordi-Ros J; Cortés F; Cucurull E; Mauri M; Buján S; Vilardell M
    J Rheumatol; 2000 Jun; 27(6):1429-33. PubMed ID: 10852265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adult discoid lupus erythematosus].
    Khelifa E; Benmously R; Fenniche S; Marrak H; Zghal M; Mokhtar I
    Tunis Med; 2007 Mar; 85(3):205-8. PubMed ID: 17668574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of chronic lupus erythematosus with sulfasalazine in 18 patients: reappraisal].
    Duparc A; Staumont-Sallé D; Broly F; Piette F; Delaporte E
    Presse Med; 2006; 35(7-8):1138-42. PubMed ID: 16840889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus.
    Sugano M; Shintani Y; Kobayashi K; Sakakibara N; Isomura I; Morita A
    J Dermatol; 2006 Dec; 33(12):887-91. PubMed ID: 17169097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfasalazine-induced lupus syndrome in a patient with Crohn's disease.
    Carr-Locke DL
    Am J Gastroenterol; 1982 Sep; 77(9):614-6. PubMed ID: 6126117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pimecrolimus 1% cream for cutaneous lupus erythematosus.
    Kreuter A; Gambichler T; Breuckmann F; Pawlak FM; Stücker M; Bader A; Altmeyer P; Freitag M
    J Am Acad Dermatol; 2004 Sep; 51(3):407-10. PubMed ID: 15337984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic cutaneous lupus erythematosus. Thalidomide treatment of 11 patients.
    Hasper MF
    Arch Dermatol; 1983 Oct; 119(10):812-5. PubMed ID: 6614949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.
    Jewell ML; McCauliffe DP
    J Am Acad Dermatol; 2000 Jun; 42(6):983-7. PubMed ID: 10827400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
    Lampropoulos CE; Sangle S; Harrison P; Hughes GR; D'Cruz DP
    Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens.
    Cuadrado MJ; Karim Y; Sanna G; Smith E; Khamashta MA; Hughes GR
    Am J Med; 2005 Mar; 118(3):246-50. PubMed ID: 15745722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.
    Woosley RL; Drayer DE; Reidenberg MM; Nies AS; Carr K; Oates JA
    N Engl J Med; 1978 May; 298(21):1157-9. PubMed ID: 306574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders of conduction in lupus erythematosus : frequency and incidence in a group of 112 patients (author's transl)].
    Godeau P; Guillevin L; Fechner J; Bletry O; Herreman G
    Ann Med Interne (Paris); 1981; 132(4):234-40. PubMed ID: 7305172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fixed lupus erythematosus (its treatment with thalidomide)].
    Barba Rubio J; Franco González F
    Med Cutan Ibero Lat Am; 1977; 5(4):279-85. PubMed ID: 364211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinuclear antibodies related to acetylator phenotype in mice.
    Tannen RH; Weber WW
    J Pharmacol Exp Ther; 1980 Jun; 213(3):485-90. PubMed ID: 6970809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of "mixed connective tissue disease" (MCTD) from discoid lupus erythematosus].
    Bauer R; Schultz-Ehrenburg U; Orfanos CE
    Hautarzt; 1981 Jan; 32(1):23-7. PubMed ID: 6971860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.